Esperion Therapeutics
ESPR
#6399
Rank
A$1.15 B
Marketcap
A$4.87
Share price
-4.51%
Change (1 day)
67.10%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): A-$0.79

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.72. In 2024 the company made an earnings per share (EPS) of A-$0.33 an increase over its 2023 EPS that were of A-$3.04.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.79137.9%
2024A-$0.33-89.15%
2023A-$3.04-40.28%
2022A-$5.10-62.87%
2021A-$13.7380.38%
2020A-$7.6150.14%
2019A-$5.07-53.18%
2018A-$10.837.41%
2017A-$10.08110.81%
2016A-$4.7847.35%
2015A-$3.250.89%
2014A-$3.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$2.47-444.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$62.38-8,788.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.53 1,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A-$0.27-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.16-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$3.91-644.00%๐Ÿ‡บ๐Ÿ‡ธ USA